Phillip Hains

Phillip Hains

Vermögen: 137 636 $ am 31.08.2026

66 Jahre
Health Technology
Non-Energy Minerals
Technology Services

Profil

Mr. Phillip A. Hains is an Independent Non-Executive Director at Hexima Ltd., a Chairman at Chimeric Therapeutics Ltd. (Australia), a Chief Financial Officer & Secretary at BKM Management Ltd., a Chief Financial Officer & Company Secretary at Myopharm Ltd. and a Secretary & Director at Radiopharm Theranostics (USA), Inc. He is on the Board of Directors at Frontier Digital Ventures Ltd., Hexima Ltd. and Radiopharm Theranostics (USA), Inc. Mr. Hains was previously employed as a Chief Financial Officer & Secretary by Radiopharm Theranostics Ltd., a Chief Financial Officer & Secretary by Klevo Rewards Ltd., a Secretary by Aura Energy Ltd., a Secretary by Arovella Therapeutics Ltd., a Chief Financial Officer by Genetic Technologies Ltd., a Chief Financial Officer by SelfWealth Ltd., a Joint Secretary by Total Brain Ltd., a Co-Secretary by Netccentric Ltd., a Chief Financial Officer & Joint Secretary by CCP Technologies Ltd., a Secretary by GetSwift Ltd., a Secretary by Surefire Resources NL, a Secretary by Sensera Ltd., a Secretary by EQUITY FINANCE LIMITED, a Secretary by Noxopharm Ltd., a Secretary by AD1 Holdings Ltd., a Secretary & Independent Non-Executive Director by Savcor Group Ltd., a Secretary by Alterity Therapeutics Ltd., a Chief Financial Officer & Secretary by Immuron Ltd., a Secretary by Rhinomed Ltd., a Joint Secretary by Im

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
30.06.2026 15 959 632 ( 0,37 % ) 114 431 $ 31.08.2026
28.08.2026 95 238 ( 0,02 % ) 23 206 $ 31.08.2026

Aktive Positionen von Phillip Hains

UnternehmenPositionBeginn
BKM MANAGEMENT LIMITED Finanzdirektor/CFO 01.12.2012
CHIMERIC THERAPEUTICS LIMITED Vorsitzender 01.10.2026
HEXIMA LIMITED Direktor/Vorstandsmitglied 18.09.2023
FRONTIER DIGITAL VENTURES LIMITED Direktor/Vorstandsmitglied 31.10.2025
Finanzdirektor/CFO -
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Phillip Hains

UnternehmenPositionEnde
RADIOPHARM THERANOSTICS LIMITED Finanzdirektor/CFO 01.05.2026
IMMURON LIMITED Finanzdirektor/CFO 09.02.2026
ALTERITY THERAPEUTICS LIMITED Finanzdirektor/CFO 30.09.2024
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Phillip Hains im Detail an

Ausbildung von Phillip Hains

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

64

Beziehungen ersten Grades

44

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen44

Commercial Services

Health Technology

Non-Energy Minerals

Technology Services

Non-Energy Minerals

Health Technology

Health Technology

Non-Energy Minerals

Health Technology

Health Technology

Finance

Consumer Non-Durables

Health Technology

Non-Energy Minerals

Health Technology

Health Technology

Non-Energy Minerals

Consumer Services

Consumer Services

Non-Energy Minerals

Consumer Durables

Health Technology

Industrial Services

CFO Solution Team Pty Ltd.

Commercial Services

Finance

Commercial Services

Commercial Services

Technology Services

Producer Manufacturing

Process Industries

Health Technology

Finance

Technology Services

Technology Services

Electronic Technology

Technology Services

Producer Manufacturing

Commercial Services

Health Technology

Health Services

Technology Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Phillip Hains